FBXW7 and prostate cancer: Because the accuracy of miR target prediction algorithms is low [14], and previous biochemical methods for identifying the targets of specific miRs are technically and analytically difficult [15–17], we used a combination of Ago-RIP-Seq and RNA-Seq following overexpression of miR-375 in PC-3 prostate cancer cells.